Patent ID: 11857604
Assignee: NH THERAGUIX
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  B | IPC A  B

Claim 18:
19. The injectable pharmaceutical solution according to claim 16, wherein the injectable pharmaceutical solution is directly obtained by means of a method for preparing a nanovector for the delivery of an active substance in a human being, said method comprising mixing two solutions that can be administered in a human being:
a. a first solution comprising a nanoparticle, said nanoparticle being a polysiloxane-based nanoparticle having a mean diameter of less than 10 nm, and
b. a second solution comprising an active substance or a mixture of active substances chosen from organic molecules,, under concentration ratio, pH and temperature conditions which allow an interaction by physisorption of the active substance or mixture of active substances at the surface of said nanoparticle.